Low molecular weight heparins (LMWH) provide a greater safety benefit than unfractionated heparin during percutaneous coronary intervention

Unfractionated Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

Safety Benefit

TCT-174: Low-Molecular-Weight Heparins vs Unfractionated Heparin in the Setting of Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: A Meta-analysis

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2011.10.180 ◽

2011 ◽

Vol 58 (20) ◽

pp. B46

Keyword(s):

Myocardial Infarction ◽

Molecular Weight ◽

Unfractionated Heparin ◽

Meta Analysis ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

St Elevation

Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors

Progress in Cardiovascular Diseases ◽

10.1016/j.pcad.2004.02.002 ◽

2004 ◽

Vol 46 (6) ◽

pp. 506-523 ◽

Cited By ~ 6

Author(s):

Spyros Kokolis ◽

Erdal Cavusoglu ◽

Luther T Clark ◽

Jonathan D Marmur

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Coronary Intervention ◽

Thrombin Inhibitors ◽

Direct Thrombin Inhibitors ◽

Low Molecular Weight ◽

Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2011.04445.x ◽

2011 ◽

Vol 9 (10) ◽

pp. 1902-1915 ◽

Cited By ~ 57

Author(s):

E. P. NAVARESE ◽

G. DE LUCA ◽

F. CASTRIOTA ◽

M. KOZINSKI ◽

P.A. GURBEL ◽

...

Keyword(s):

Myocardial Infarction ◽

Molecular Weight ◽

Unfractionated Heparin ◽

Meta Analysis ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Percutaneous Coronary ◽

St Elevation

Intravenous Low-Molecular-Weight Heparins Compared With Unfractionated Heparin in Percutaneous Coronary Intervention

Archives of Internal Medicine ◽

10.1001/archinte.167.22.2423 ◽

2007 ◽

Vol 167 (22) ◽

pp. 2423 ◽

Cited By ~ 49

Author(s):

Raphaelle Dumaine

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Corrigendum to “Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention” [Indian Heart J. 68 (2) (2016) 213–224]

Indian Heart Journal ◽

10.1016/j.ihj.2017.08.024 ◽

2017 ◽

Vol 69 (5) ◽

pp. e1

Author(s):

Sadeq Ali-Hasan-Al-Saegh ◽

Seyed Jalil Mirhosseini ◽

Azadeh Shahidzadeh ◽

Parisa Mahdavi ◽

Mahbube Tahernejad ◽

...

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention

Indian Heart Journal ◽

10.1016/j.ihj.2016.01.014 ◽

2016 ◽

Vol 68 (2) ◽

pp. 213-224 ◽

Cited By ~ 2

Author(s):

Sadegh Ali-Hassan-Sayegh ◽

Seyed Jalil Mirhosseini ◽

Azadeh Shahidzadeh ◽

Parisa Mahdavi ◽

Mahbube Tahernejad ◽

...

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: A combined analysis

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.20352 ◽

2005 ◽

Vol 65 (2) ◽

pp. 212-221 ◽

Cited By ~ 22

Author(s):

Maria Borentain ◽

Gilles Montalescot ◽

Anissa Bouzamondo ◽

Rémi Choussat ◽

Jean-Sébastien Hulot ◽

...

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Low Molecular Weight Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Combined Analysis ◽

Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention

JAMA ◽

10.1001/jama.289.3.331 ◽

2003 ◽

Vol 289 (3) ◽

pp. 331 ◽

Cited By ~ 66

Author(s):

Graham C. Wong ◽

Robert P. Giugliano ◽

Elliott M. Antman

Keyword(s):

Molecular Weight ◽

Coronary Artery ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Prospective, Randomized, Preliminary Clinical Trial with Low-Molecular-Weight Heparin or Unfractionated Heparin as Periprocedural Anticoagulant during Elective Percutaneous Coronary Intervention

Korean Circulation Journal ◽

10.4070/kcj.2006.36.8.573 ◽

2006 ◽

Vol 36 (8) ◽

pp. 573 ◽

Cited By ~ 1

Author(s):

Sung-Ho Her ◽

Ki-Bae Seung ◽

Hee-Jeong Yoon ◽

Dong-Bin Kim ◽

Dong-Il Shin ◽

...

Keyword(s):

Clinical Trial ◽

Molecular Weight ◽

Unfractionated Heparin ◽

Low Molecular Weight Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Preliminary Clinical Trial ◽

Elective Percutaneous Coronary Intervention ◽

2050 Effects of antithrombotic regimen on the early outcome in the FRACAS study: incremental beneficial effects of low molecular weight heparin and thlenopyridine in patients undergoing subsequent percutaneous coronary intervention

European Heart Journal ◽

10.1016/s0195-668x(03)95047-0 ◽

2003 ◽

Vol 24 (5) ◽

pp. 378

Author(s):

M ANGIOL

Keyword(s):

Molecular Weight ◽

Low Molecular Weight Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Early Outcome ◽

Beneficial Effects ◽